HTS platform for identification of regulators of cell adhesion molecule signaling
HTS platform for identification of regulators of cell adhesion molecule signaling
批准号:
8607886
负责人:
DARREN G WOODSIDE
金额:
$38.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-07 至 2016-01-31
关键词:
AdhesionsAdhesivesAdverse effectsAffinityAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesArtificial MembranesAtherosclerosisAutoimmune ProcessAutoimmunityBasic ScienceBindingBiological AssayBlood PlateletsCalorimetryCardiovascular DiseasesCell AdhesionCell Adhesion MoleculesCell Membrane PermeabilityCell surfaceCellsChemicalsClinicalClot retractionCollagenCytoplasmic TailDevelopmentDiseaseDoseDrug KineticsDrug TargetingEpitopesExtracellular DomainExtracellular MatrixFamilyFibrinogenFibronectinsFutureGTP-Binding ProteinsGenomicsGoalsHemorrhageHemostatic functionHomologous GeneImmunosuppressionImmunosuppressive AgentsIn VitroIndustryInflammationInflammatoryIntegrin BindingIntegrin beta3IntegrinsLeadLeftLibrariesLigand BindingLigandsMediatingMetricMolecularMolecular BankMutationNIH Program AnnouncementsNeoplasmsPathogenesisPatientsPeptidesPharmaceutical PreparationsPharmacologic SubstancePhysiologicalPhysiological ProcessesPlatelet aggregationPlayProcessProductionProtein SubunitsProtein Tyrosine KinaseReactionReceptor Cross-TalkReceptor SignalingRegulationResearchRoleSerumSignal TransductionSignaling MoleculeSpecificityStructureSurface Plasmon ResonanceSystemTalinTechnologyTestingTherapeuticThrombocytopeniaTitrationsTriageUnited States National Institutes of HealthValidationVascular Cell Adhesion Molecule-1acute coronary syndromeadhesion receptorassay developmentatherothrombosisbasedrug candidateextracellularhigh throughput screeningin vivoleukocyte activationmeetingsmicrocalorimetrymimeticsnovelnovel strategiespreventpublic health relevancereceptorresponsescaffoldscreeningsmall moleculetirofibantool
中文摘要
描述(由申请人提供):以下提案是对项目公告PA-10-213题为“开发用于探针和治疗前发现的高通量筛选测定法(R01)”的回应。整合素细胞粘附受体在正常生理过程中发挥重要作用,并与肿瘤、自身免疫、炎症和心血管疾病有关。事实上,它们是经过验证的药物靶点。目前以整合素为基础的治疗方法在治疗患者方面已被证明是无价的,但由于与免疫抑制和诱导自身免疫反应相关的副作用而受到限制。需要一种新的策略来靶向整合素,从而消除副作用。整合素结合多种细胞外配体,如血清纤维蛋白原、细胞外基质(ECM)成分和细胞表面计数器受体。它们的活性受到细胞内支架分子(如Talin-1和Kindlins)的严格调节,这些分子可以结合到整合素细胞质结构域,并在称为“内向外”的信号传导过程中增加整合素对配体的外结构域亲和力。整合素也作为信号受体,其中“由外而内”的信号传导是由整合素细胞质结构域和细胞内效应物(如Syk家族的非受体酪氨酸激酶)之间的直接相互作用介导的。我们已经开发了一个无细胞检测平台,用于高通量筛选(HTS)小分子化合物文库,用于整合素细胞质结构域和细胞内效应分子之间相互作用的拮抗剂。该系统采用放大发光接近均相分析(ALPHA)屏幕格式。在我们的第一个目标中,我们建议开发一套针对整合素β 3细胞质结构域与Syk、Kindlin-3和Galpha13结合的初级HTS检测。此外,还将开发一种辅助筛选系统,以对假阳性结果进行分类。在第二个目标中,我们提出了一些正交试验,从基于elisa的方法到等温滴定量热法和表面等离子体共振,这将有助于验证命中特异性和选择性。最后,一个
英文摘要
DESCRIPTION (provided by applicant): The following proposal is in response to the program announcement PA-10-213 titled "Development of Assays for High-Throughput screening for use in Probe and Pre-therapeutic Discovery (R01)." Integrin cell adhesion receptors play essential roles in normal physiologic process and have been implicated in neoplasia, autoimmunity, inflammation, and cardiovascular disease. Indeed, they are validated drug targets. Present integrin-based therapeutics has proven invaluable in the treatment of patients but is limited by side-effects related to immunosuppression and the induction of autoimmune reactions. There is need for a new strategy to target integrins that would eliminate side-effects. Integrins bind a variety of extracellular ligands such as serum fibrinogen, extracellular matrix (ECM) components, and cell-surface counter receptors. Their activity is tightly regulated by intracellula scaffolding molecules such as Talin-1 and Kindlins that can bind to integrin cytoplasmic domains and in a process termed "inside-out" signaling increase integrin ectodomain affinity for ligand. Integrins also serve as signaling receptors, where "outside-in" signaling is mediated by direct interactions between integrin cytoplasmic domains and intracellular effectors such as the Syk family of nonreceptor tyrosine kinases. We have developed a cell-free assay platform for high throughput screening (HTS) of small molecule compound libraries for antagonists of the interactions between integrin cytoplasmic domains and intracellular effector molecules. This system utilizes the amplified luminescent proximity homogenous assay (ALPHA) screen format. In our first aim, we propose to develop a suite of primary HTS assays targeting the binding of integrin beta3 cytoplasmic domains with Syk, Kindlin-3, and Galpha13. A secondary screen to triage false positive hits will also be developed. In a second aim, we propose a number of orthogonal assays ranging from Elisa-based approaches to isothermal titration calorimetry and surface plasmon resonance, which will serve to validate hit specificity and selectivity. Finally, a
third aim is proposed to test antagonist mechanism of action in primary cells, examining integrin activation of Syk, integrin affinity regulation, and platelet function. All primary ALPHA screens will be optimized according to HTS metrics as guided by the NIH Chemical Genomics Center. Pilot screens of a small molecule compound library will be performed to demonstrate primary and secondary screen tractability. Small molecule antagonist identified here may represent excellent starting points for the development of novel classes of anti-platelet and anti-inflammatory drug candidates, which could target integrin function at the intracellular level. Furthermore, small molecule compounds derived from the HTS assays proposed here could be important novel tools in the analysis of both "inside-out" and "outside-in" integrin signal transduction.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fimmu.2020.575085
发表时间:
2020
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Bakthavatsalam D, Craft JW Jr, Kazansky A, Nguyen N, Bae G, Caivano AR, Gundlach CW 4th, Aslam A, Ali S, Gupta S, Lin SY, Parthiban HD, Vanderslice P, Stephan CC, Woodside DG]
通讯作者:
Woodside DG
HTS platform for identification of regulators of cell adhesion molecule signaling
-
批准号:8420443
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2012
-
负责人:DARREN G WOODSIDE
-
依托单位:
HTS platform for identification of regulators of cell adhesion molecule signaling
-
批准号:8295318
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2012
-
负责人:DARREN G WOODSIDE
-
依托单位:
海外基金